Insider Transactions in Q4 2023 at Mi Nk Therapeutics, Inc. (INKT)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 01 2023	Barbara Ryan	BUY Grant, award, or other acquisition	Direct	17,068 +20.08%	$17,068 $1.04 P/Share
Dec 01 2023	Peter Behner	BUY Grant, award, or other acquisition	Direct	14,784 +20.08%	$14,784 $1.04 P/Share
Dec 01 2023	Ulf Wiinberg	BUY Grant, award, or other acquisition	Direct	14,424 +16.21%	$14,424 $1.04 P/Share
Dec 01 2023	Brian Corvese	BUY Grant, award, or other acquisition	Direct	17,188 +4.72%	$17,188 $1.04 P/Share
Oct 16 2023	Agenus Inc	BUY Open market or private purchase	Direct	429 +0.0%	$429 $1.1 P/Share
Oct 13 2023	Agenus Inc	BUY Open market or private purchase	Direct	19,373 +0.09%	$19,373 $1.1 P/Share
Oct 12 2023	Agenus Inc	BUY Open market or private purchase	Direct	3,173 +0.01%	$3,173 $1.1 P/Share
Oct 11 2023	Jennifer Buell Chief Executive Officer	SELL Other acquisition or disposition	Direct	695,750 -74.98%	-
Oct 04 2023	Agenus Inc	BUY Open market or private purchase	Direct	15,001 +0.07%	$15,001 $1.09 P/Share
Oct 03 2023	Jennifer Buell Chief Executive Officer	SELL Payment of exercise price or tax liability	Direct	65,000 -6.55%	$0 $0.94 P/Share
Oct 02 2023	Jennifer Buell Chief Executive Officer	SELL Payment of exercise price or tax liability	Direct	58,550 -5.57%	$58,550 $1.04 P/Share

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Value

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

Operation

Value

Type

Receive news related to MiNK Therapeutics, Inc.